HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION

Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025 Medical Supply Chain Resiliency Act (S. 998/HR 2213) Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act. Health cybersecurity legislation. Implementation of the Drug Supply Chain Security Act (DSCSA).

Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025. S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act. Monitoring of labor issues and work stoppages resulting from the International Longshoreman's Association strike affecting ports on the East Coast of the United States.

Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025. Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)